Penile rehabilitation.
Katz
Anne
A
CancerCare Manitoba, Winnipeg, Manitoba, Canada. anne.katz@cancercare.mb.ca
D000527:Alprostadil / Q000627:therapeutic use; D002243:Carbolines / Q000627:therapeutic use; D015984:Causality; D002985:Clinical Protocols; D007172:Erectile Dysfunction / Q000209:etiology / Q000534:rehabilitation*; D005355:Fibrosis; D006801:Humans; D008297:Male; D024802:Nurse's Role; D015917:Penile Prosthesis; D010413:Penis / Q000473:pathology; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011182:Postoperative Care / Q000379:methods / Q000451:nursing; D011468:Prostatectomy / Q000009:adverse effects / Q000534:rehabilitation; D011687:Purines / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use; D000068581:Tadalafil; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
D002243:Carbolines; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068581:Tadalafil; D000068677:Sildenafil Citrate; D000527:Alprostadil